【what is a rinseless wash】Adamis Has 'Favorable' Pipeline Setup, Says Bullish Raymond James

Adamis what is a rinseless washPharmaceuticals Corp

(NASDAQ:

【what is a rinseless wash】Adamis Has 'Favorable' Pipeline Setup, Says Bullish Raymond James


ADMP

【what is a rinseless wash】Adamis Has 'Favorable' Pipeline Setup, Says Bullish Raymond James


)

【what is a rinseless wash】Adamis Has 'Favorable' Pipeline Setup, Says Bullish Raymond James


announced


its NDA filing Friday for a fast-dissolving sublingual tadalafil tablet for erectile dysfunction.


The Analyst


Raymond James analyst Elliot Wilbur maintained an Outperform on


Adamis.


The Thesis


The submission of the NDA is positive, as an approval would place Adamis in the $4-billion-plus phosphodiesterase inhibitor market, Wilbur said in a Monday note.


Even a small conversion rate could translate to a $150-million top-line opportunity, the analyst said.


Raymond James expects the FDA decision to come through in the fourth quarter, with a potential commercial launch in 2020.


The stock price has factored in a Symjepi launch in Q1, but is not adequately reflecting other pipeline assets, Wilbur said.


The approval of tadalafil would pitch Adamis against


Eli Lilly And Co


(NYSE:


LLY


)'s Cialis and


Pfizer Inc.


(NYSE:


PFE


)'s recently genericized Viagra, as well as vardenafil, a combo drug consisting of Levitra and Staxyn from


GlaxoSmithKline plc


(NYSE:


GSK


).


"We reiterate our Outperform rating as the company continues to make forward progress and provides better visibility on timelines," Wilbur said. "We believe the risk-reward scenario given the pipeline setup is favorable with significant upside."


The Price Action


Adamis shares were up 3.11 percent at $2.32 at the time of publication Wednesday.


Related Links:


Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates


6 Valuable Pipeline Drugs With Upcoming Catalysts


Latest Ratings for ADMP


Nov 2018


B. Riley FBR


Downgrades


Buy


Neutral


May 2018


Maxim Group


Maintains


Buy


Buy


Apr 2018


H.C. Wainwright


Initiates Coverage On


Buy


View More Analyst Ratings for ADMP


View the Latest Analyst Ratings


See more from Benzinga


Natural Gas, Uranium, Palladium Are Commodity Winners; Base Metals Battered


Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates


The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials


© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


View comments


Fashion
上一篇:Skyworks Solutions (SWKS) Matches Q2 Earnings Estimates
下一篇:eXp World Holdings Appoints Fee Gentry to Board of Directors